October 20, 2019

Just in time for Breast Cancer Awareness Month our latest Precision Medicine article: 
Personalizing Decision-Making for Patients Choosing Contralateral Prophylactic Mastectomy


May 25, 2011

Live ‘Liquid Facelift’ demo one of the highlights of upcoming Open House at Loma Linda University Health Care Clinic in Riverside

FOR IMMEDIATE RELEASE

CONTACT:
Herbert Atienza
Media Relations Specialist
Loma Linda University Medical Center
Phone: 909-558-3457
E-mail: hatienza@llu.edu



--------------------------------------------------------------------------------

RIVERSIDE, CA – May 25, 2011 – A live video feed of a “Liquid Facelift” technique from one of the treatment rooms to a parking lot theater screen is one of the expected highlights of an upcoming Open House at the Riverside clinic of Loma Linda University Health Care Department of Plastic Surgery.

The open house is set for 1 p.m. to 4 p.m. on Friday, June 3, at the Plastic Surgery of Riverside, 3762 Tibbetts St., Riverside, Calif., 92506.

“Liquid Facelift” is a popular aesthetic procedure that uses Botox and fillers instead of surgery to rejuvenate a person’s appearance. At the open house, participants will be able to see how the procedure is done via live video feed. Plastic surgery experts will also give presentations on body contouring and how to get ready for a special event -- such as a wedding, a high school reunion, or a special night out -- by combining diet, exercise, skin care and aesthetic procedures.

“We are very proud and happy to host this open house,” said Dr. Subhas Gupta, chairman of the Loma Linda University Health Care Department of Plastic Surgery. “As always, these events provide a time for people to talk informally with many of our plastic surgeons. Patients frequently report that this is a great time to ask “questions you always wanted to know the answer to, but were afraid to ask!”

Dr. Gupta will be joined by fellow plastic surgeon, Dr. Michael E. Hill, in the following free educational demonstrations and presentations: 1:30 p.m. – "Liquid Facelift" demonstration; 2:15p.m. – Innovative Body Contouring; 3:15 p.m. – Your Time To Shine - Get Ready for Your Big Day. E-mail info@lluplasticsurgery.com or call 951-686-2224 for more information and to confirm your spot for the presentations.

Guests at the open house may also avail of discounts for aesthetic procedures and products, including $100 off regular price for injectables, such as Botox, Dysport, Juvederm, Prevelle, Perlane and Restylane; and $100 off the regular price for facial rejuvenation laser treatments. Limited appointments will be made for injections throughout the day.

###

About Loma Linda University Health Care - LLUHC
Loma Linda University Health Care (LLUHC) is the management service organization that supports the many programs and services provided by our 400+ faculty physicians. These physicians are employed by Loma Linda University professional corporations and make up what is known as the faculty practice plan. These physicians are family practice, general medicine and general pediatric primary care specialists, as well as various medical and surgical specialties and subspecialties. The faculty practice plan of Loma Linda University accounts for over 40,000 patient office visits a month. Seventy-five percent of these visits occur in the Faculty Medical Offices, a professional office building located south of Barton Road on the corner of Barton Road and Anderson Street. There are other clinic locations such as the Professional Plaza at 25455 Barton Road next to Loma Linda University Medical Center East Campus, and other sites throughout the surrounding area.

April 10, 2010

FDA issues warnings about fat-melting injections used in spas

Leading Aesthetic news from the AMA
- posted by @plsurgeon
(www.plsurgeon.com)

FDA issues warnings about fat-melting injections used in spas across the US.

The AP (4/8, Perrone) reports that "the Food and Drug Administration is cracking down on what are billed as fat-melting injections used in spas across the US, saying the drugs" have not "been cleared by federal scientists, as required by law." The agency asked a Brazilian company and six medical spas in the US to provide a written response within 15 days with their action plan to correct the situation, the Wall Street Journal (4/8, Stynes) reports.

The Philadelphia Inquirer (4/8, Burling) explains, "In a procedure known variously as lipodissolve, mesotherapy, lipozap, lipotherapy, or injection lipolysis, patients receive a series of injections meant to 'dissolve and permanently remove small pockets of fat from various parts of the body,' the FDA said. The primary ingredients are phosphatidylcholine and deoxycholate, although vitamins and herbs may also be added." The agency "has not evaluated the drugs and says it knows of no 'credible scientific evidence' that shows they eliminate fat."

No "definitive studies of side effects" have been reported, and the risks of the injections "also aren't understood," the NPR (4/7, Popovich) "Shots" blog reported. However, some patients have experienced "pain at the injection site, knots under the skin, and permanent scarring."

Nevertheless, the CNN (4/7, Willingham) "Paging Dr. Gupta" blog reported that "the companies have been cited for a variety of regulatory violations, including making unsupported claims that the products have an outstanding safety record and are superior to other fat loss procedures, including liposuction."

According to HealthDay (4/7, Reinberg), "some of these companies have claimed that lipodissolve can treat certain medical conditions, such as male breast enlargement, benign fatty growths called lipomas, excess fat deposits, and surgical deformities."

WebMD (4/7, Mann) reported that the six companies receiving warnings in the US include Monarch Medspa in King of Prussia, PA; Spa 35 in Boise, ID; Medical Cosmetic Enhancements in Chevy Chase, MD; Innovative Directions in Health in Edina, MN, PURE Med Spa in Boca Raton, FL, and All About You Med Spa in Madison, IN. In addition, the agency "admonished a Brazilian company for hawking lipodissolve products on two websites: zipmed.net and mesoone.com." The FDA has also "issued an import alert to prevent the importation and distribution of unapproved lipodissolve drug products into the United States."

MedPage Today (4/7, Smith) reported that Kathleen Anderson, PharmD, of the FDA's Center for Drug Evaluation and Research, explained that if the companies' response to the FDA's letter is unsatisfactory, "they could face injunctions, seizure of the products, and civil or criminal action." The Idaho Statesman (4/8, Sewell), CQ HealthBeat (4/8, Reichard), and Reuters (4/8) also cover the story.

Subhas Gupta, MD, CM, PhD, FRCSC, FACS
Chief of Surgical Services | Loma Linda University Medical Center
Chairman, Professor, and Residency Director | The Department of Plastic Surgery
11175 Campus Street, CP21126, Loma Linda, CA 92350
Phone: (909) 558-8085 · Fax: (909) 558-4175

Just in time for Breast Cancer Awareness Month our latest Precision Medicine article:   Personalizing Decision-Making for Patients Choosin...